KORU Medical’s Freedom60 pump receives EU MDR certification
#KORU Medical #Freedom60 #infusion pump #EU MDR #certification #medical device #subcutaneous delivery
📌 Key Takeaways
- KORU Medical's Freedom60 infusion pump has received EU MDR certification.
- The certification ensures compliance with the European Union's Medical Device Regulation.
- This approval allows the pump to be marketed and sold in the European market.
- The Freedom60 is designed for subcutaneous drug delivery, often used in home care settings.
🏷️ Themes
Medical Devices, Regulatory Approval
Entity Intersection Graph
No entity connections available yet for this article.
Deep Analysis
Why It Matters
This news is important because EU MDR certification is a stringent regulatory requirement for medical devices sold in the European Union, ensuring safety and performance. It affects KORU Medical by enabling continued and expanded market access in Europe, potentially boosting revenue and competitiveness. Patients relying on subcutaneous immunoglobulin therapies benefit from assured device quality, while healthcare providers gain confidence in using a certified infusion pump for chronic conditions like primary immunodeficiency.
Context & Background
- The EU Medical Device Regulation (MDR) replaced the previous Medical Device Directive (MDD) in May 2021, imposing stricter requirements for clinical evidence, post-market surveillance, and transparency.
- KORU Medical Systems is a U.S.-based company specializing in subcutaneous infusion systems, with the Freedom60 pump designed for home-based therapies such as immunoglobulin treatments.
- The MDR transition has posed challenges for many medical device manufacturers, with delays and increased costs, making timely certification critical for maintaining EU market presence.
What Happens Next
KORU Medical will likely proceed with commercial launches or expansions in European countries, targeting healthcare providers and patients. The company may also pursue additional certifications or updates to align with evolving MDR requirements. In the short term, expect increased marketing efforts and potential partnerships to drive adoption of the Freedom60 pump in EU markets.
Frequently Asked Questions
EU MDR certification is a regulatory approval under the European Union's Medical Device Regulation, ensuring that medical devices meet high safety, performance, and quality standards for sale and use in the EU market.
This certification allows KORU Medical to legally market and sell its Freedom60 pump in the EU, avoiding disruptions and capitalizing on a key market for medical devices, which can enhance growth and patient access.
The Freedom60 pump enables convenient, home-based subcutaneous infusion therapies, such as for immunoglobulin deficiencies, improving quality of life by reducing hospital visits and offering portability and ease of use.
Companies face challenges like rigorous clinical data requirements, increased documentation, higher costs, and potential delays in certification, which can impact market access and competitiveness if not managed effectively.